Kardham Group reorganizes its capital to accelerate growth

On the occasion of its 30th anniversary, the KARDHAM Group, France's leading independent and integrated player in professional real estate, announces that GENEO Capital Entrepreneur and Bpifrance are strengthening their presence in Kardham's capital, having been present alongside management since 2020 and 2016 respectively.

GENEO Capital Entrepreneur officially sets up its mission committee

GENEO Capital Entrepreneur's Mission Committee held its first official meeting today, marking another concrete step in the transformation of GENEO into a mission-driven company, effective May 19, 2023. This committee will be responsible for monitoring the execution of the mission and the strategic and operational implementation of GENEO's raison d'être: "to provide the real economy with positive finance that reconciles performance and meaning".

GENEO Capital Entrepreneur supports GBNA Santé in its acquisition of Francheville Périgord Santé

GENEO Capital Entrepreneur supported GBNA Santé in the acquisition of three facilities from the Francheville Perigord Santé group, strengthening GBNA's position as a leading hospital group in the Nouvelle-Aquitaine region, with a total of 12 healthcare facilities. This acquisition, announced in June and formally completed in September, was partly financed by a capital increase in which GENEO Capital Entrepreneur, which has been supporting GBNA since 2021, participated along with UI Investissement.

ChapsVision announces €90 million funding round to accelerate growth in the European market

ChapsVision, the data enhancement specialist, raises €90 million to accelerate its development on the European market through targeted acquisitions. This round of financing is led by Qualium Investissement with the participation of GENEO, and historical investors Tikehau Capital and Bpifrance, who have subscribed to this new round of funding.

GENEO Capital Entrepreneur brings together a group of long-term investors to support Actéo in its growth and the evolution of its governance.

GENEO Capital entrepreneur supports the Actéo group, which specializes in the manufacture (Théolaur) and distribution of paints and complementary products for the building industry (Théodore Maison de Peinture), in the evolution of its capital with a view to accelerating its development projects, notably around innovation, its low-carbon approach and digital. This transaction is part of a long-term, positive-impact investment strategy.